HKPD
Hong Kong Pharma Digital Technology Holdings Ltd (HKPD)
Healthcare • NASDAQ • $0.62-2.75%
- Symbol
- HKPD
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Distribution
- Price
- $0.62
- Daily Change
- -2.75%
- Market Cap
- $14.63M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $2.76
- 52W Low
- $0.37
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- N/A
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
Company websiteResearch HKPD on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.